Inactive Instrument

Other languages Ambrx Biopharma Inc.

Equities

Ambrx Biopharma Inc. Announces Resignation of Andrew Aromando as Chief Operating Officer	03-12
Johnson & Johnson Completes Ambrx Acquisition	03-07
J&J : finalise l'acquisition d'Ambrx Biopharma pour 2 Mds$	03-07
Johnson & Johnson completed the acquisition of Ambrx Biopharma Inc. from a group of shareholders.	03-06
Ambrx Biopharma Shareholders Approve Johnson & Johnson Acquisition Deal	03-06
J&J's Acquisition of Ambrx Biopharma Completes Hart-Scott-Rodino Waiting Period	02-22
Le bric-à-brac de Zonebourse : Trois records historiques, une galaxie lointaine et du M&A	02-06
Tiens, revoilà Nvidia	01-09
En Direct des Marchés : Airbus, Sanofi, Dassault Aviation, Trigano, Samsung, Novartis, GSK...	01-09
EN DIRECTO DESDE LOS MERCADOS: Grifols, Airbus, Boeing, Sony, Shell, Nike, Brunello Cucinelli, Samsung, J&J, GSK...	01-09
Bolsa de Madrid: ¡Nvidia ha vuelto!	01-09
MÄRKTE USA/Dow dreht ins Plus - Nasdaq gewinnt über 2%	01-08
Sector Update: Health Care Stocks Rise Late Afternoon	01-08
Sector Update: Health Care Stocks Rise in Afternoon Trading	01-08
Top Midday Gainers	01-08
LATE BRIEFING - Unternehmen und Märkte -2-	01-08
LATE BRIEFING - Unternehmen und Märkte	01-08
MÄRKTE USA/Dow-Jones-Index von Boeing belastet - Nasdaq +1,2%	01-08
Drugmakers kick off industry conference with two cancer deals	01-08
Johnson & Johnson Strikes $2 Billion Deal to Take Ambrx Biopharma Private	01-08

No results for this search